BIOQUAL, Inc.
BIOQ
$55.00
-$1.00-1.79%
| 11/30/2024 | 08/31/2024 | 11/30/2023 | 11/30/2023 | 05/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -28.19% | -24.45% | -4.84% | -4.84% | -12.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.19% | -24.45% | -4.84% | -4.84% | -12.40% |
| Cost of Revenue | -13.68% | -9.73% | 2.28% | 2.28% | 1.82% |
| Gross Profit | -104.48% | -85.54% | -30.35% | -30.35% | -33.39% |
| SG&A Expenses | -13.58% | -15.50% | 8.72% | 8.72% | 6.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.67% | -10.47% | 3.07% | 3.07% | 3.34% |
| Operating Income | -423.54% | -196.95% | -69.20% | -69.20% | -160.21% |
| Income Before Tax | -350.13% | -175.07% | -63.44% | -63.44% | -157.55% |
| Income Tax Expenses | -350.24% | -175.07% | -65.63% | -65.63% | -332.27% |
| Earnings from Continuing Operations | -350.09% | -175.08% | -62.54% | -62.54% | -137.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -350.09% | -175.08% | -62.54% | -62.54% | -137.20% |
| EBIT | -423.54% | -196.95% | -69.20% | -69.20% | -160.21% |
| EBITDA | -202.09% | -128.35% | -49.69% | -49.69% | -119.51% |
| EPS Basic | -350.10% | -175.07% | -62.54% | -62.54% | -137.20% |
| Normalized Basic EPS | -350.13% | -175.07% | -63.44% | -63.44% | -157.55% |
| EPS Diluted | -351.85% | -175.57% | -62.67% | -62.67% | -137.44% |
| Normalized Diluted EPS | -350.13% | -175.07% | -63.44% | -63.44% | -157.55% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -50.00% |
| Payout Ratio | -1.40% | -- | 0.33% | 0.33% | -- |
